These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34332622)

  • 21. Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea.
    Marme G; Kuzma J; Zimmerman PA; Harris N; Rutherford S
    J Public Health (Oxf); 2024 May; 46(2):267-276. PubMed ID: 38326281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges and opportunities for infection prevention and control in hospitals in conflict-affected settings: a qualitative study.
    Lowe H; Woodd S; Lange IL; Janjanin S; Barnet J; Graham W
    Confl Health; 2021 Dec; 15(1):94. PubMed ID: 34930364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home Health Staff Perspectives on Infection Prevention and Control: Implications for Coronavirus Disease 2019.
    Pogorzelska-Maziarz M; Chastain AM; Mangal S; Stone PW; Shang J
    J Am Med Dir Assoc; 2020 Dec; 21(12):1782-1790.e4. PubMed ID: 33256957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations.
    Storr J; Twyman A; Zingg W; Damani N; Kilpatrick C; Reilly J; Price L; Egger M; Grayson ML; Kelley E; Allegranzi B;
    Antimicrob Resist Infect Control; 2017; 6():6. PubMed ID: 28078082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring behavioural factors influencing COVID-19-specific infection prevention and control measures in Finland: a mixed-methods study, December 2020 to March 2021.
    Lohiniva AL; Toura S; Arifulla D; Ollgren J; Lyytikäinen O
    Euro Surveill; 2022 Oct; 27(40):. PubMed ID: 36205170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A continent-wide effort and solidarity at curbing COVID-19 pandemic: the Africa task force for novel coronavirus (AFTCOR) infection prevention and control technical working group's experience.
    Paintsil E; Alimi Y; Abdulaziz M; Ogbuagu O; Ogunsola F; Kessy SJ; Horsney E; Lee C; Brundney K; Okwor T; Kabwe P; Waheed A; Vondran A; Bigirimana R; Ilesanmi O; Nsubuga DN; Raji T; Mankoula W; Ihekweazu C; Nkengasong J
    BMC Public Health; 2023 May; 23(1):893. PubMed ID: 37189137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of World Health Organization Guidelines in the Prevention of Surgical Site Infection in Low- and Middle-Income Countries:What We Know and Do Not Know.
    Rasa K; Kilpatrick C
    Surg Infect (Larchmt); 2020 Sep; 21(7):592-598. PubMed ID: 32478641
    [No Abstract]   [Full Text] [Related]  

  • 29. First nationwide survey of infection prevention and control among healthcare facilities in Japan: impact of the national regulatory system.
    Nomoto H; Saito H; Ishikane M; Gu Y; Ohmagari N; Pittet D; Kunishima H; Allegranzi B; Yoshida M
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):135. PubMed ID: 36352429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core components of infection prevention and control programs at the facility level in Kazakhstan: key challenges and opportunities.
    Deryabina A; Aiypkhanova A; Juvashev A; Alimbetov K; Tekebayev K; Kassa G; Howard AA
    Antimicrob Resist Infect Control; 2023 Jun; 12(1):59. PubMed ID: 37349829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and core components of infection prevention and control programmes in long-term care facilities: a systematic review.
    Lee MH; Lee GA; Lee SH; Park YH
    J Hosp Infect; 2019 Aug; 102(4):377-393. PubMed ID: 30794854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection prevention and control for COVID-19 response in the Rohingya refugee camps in Bangladesh: an intra-action review.
    Apolot RR; Kaddu SS; Evers ES; Debashish P; Mowla SMN; Ahmed S; Das A; Bhuiyan ATMRH; Rahman MM; Barua A; Maina AGK; Sultan M; Nyawara M; Willet V; Von Harbou K
    Int J Equity Health; 2023 Jun; 22(1):111. PubMed ID: 37277825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative study of infection prevention and control practices in the maternal units of two Ghanaian hospitals.
    Sunkwa-Mills G; Senah K; Breinholdt M; Aberese-Ako M; Tersbøl BP
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):125. PubMed ID: 37953285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of infection prevention and control practices in an upcoming COVID-19 hospital in India: An opportunity not missed.
    Das A; Garg R; Kumar ES; Singh D; Ojha B; Kharchandy HL; Pathak BK; Srikrishnan P; Singh R; Joshua I; Nandekar S; J V; Reghu R; Pedapanga N; Banerjee T; Yadav KK
    PLoS One; 2022; 17(5):e0268071. PubMed ID: 35604919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining the discourse regarding the delivery of occupational infection prevention and control training to healthcare workers: a scoping review of pandemic plans of 23 countries.
    Qureshi MO; Chughtai AA; Islam MS; Tuckerman J; Seale H
    BMJ Open; 2022 Aug; 12(8):e061850. PubMed ID: 36002207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations related to occupational infection prevention and control training to protect healthcare workers from infectious diseases: a scoping review of infection prevention and control guidelines.
    Qureshi MO; Chughtai AA; Seale H
    BMC Health Serv Res; 2022 Mar; 22(1):272. PubMed ID: 35232449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The status of infection prevention and control structures in Eastern China based on the IPCAF tool of the World Health Organization.
    Ni K; Jin D; Wu Z; Sun L; Lu Q
    Antimicrob Resist Infect Control; 2022 Mar; 11(1):46. PubMed ID: 35264208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing and implementing an infection prevention and control program for a COVID-19 alternative care site in Philadelphia, PA.
    Tadavarthy SN; Finnegan K; Bernatowicz G; Lowe E; Coffin SE; Manning M
    Am J Infect Control; 2021 Jan; 49(1):77-81. PubMed ID: 32697947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China?
    Lai X; Wang X; Yang Q; Xu X; Tang Y; Liu C; Tan L; Lai R; Wang H; Zhang X; Zhou Q; Chen H
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):83. PubMed ID: 32527300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.